Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 25;14(5):406.
doi: 10.3390/ph14050406.

COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials

Zhi-Peng Yan  1 , Ming Yang  2 , Ching-Lung Lai  1
Affiliations
Review

COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials

Zhi-Peng Yan et al. Pharmaceuticals (Basel). .

Abstract

Various strategies have been designed to contain the COVID-19 pandemic. Among them, vaccine development is high on the agenda in spite of the unknown duration of the protection time. Various vaccines have been under clinical trials with promising results in different countries. The protective efficacy and the short-term and long-term side effects of the vaccines are of major concern. Therefore, comparing the protective efficacy and risks of vaccination is essential for the global control of COVID-19 through herd immunity. This study reviews the most recent data of 12 vaccines to evaluate their efficacy, safety profile and usage in various populations.

Keywords: COVID-19; efficacy; herd immunity; safety; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors Zhipeng Yan, Ming Yang and Ching-Lung Lai declare there is no conflict of interest.

Figures

Figure 1
Figure 1
Schematic graph of the comparison between DNA and mRNA vaccine in terms of mechanisms. DNA vaccine is a circle DNA which contains the spike gene of SARS-CoV-2. After electroporation, cell membrane permeation will be increased, allowing DNA enter into cytoplasm thereby reaching to the nuclear. Subsequently, DNA will be translated into mRNA, which will be further translated into SARS-CoV-2 spike proteins and express on cell membrane. Nanoparticle-encapsulated mRNA encoding SARS-CoV-2 antigen will be integrated into cytoplasm. The spike mRNA utilizes ribosome and bases to translate spike proteins, which express on the cell membrane. The membrane spike protein will be recognized by antigen presenting cell (APC) thereby activating immune reaction.
See this image and copyright information in PMC

References

    1. World Health Organization [(accessed on 25 March 2021)];Weekly Epidemiology Update 23 February 2021. 2021 WHO Situation Report. Available online: https://www.who.int/publications/m/item/weekly-epidemiological-update---....
    1. Bonam S.R., Kotla N.G., Bohara R.A., Rochev Y., Webster T.J., Bayry J. Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections. Nano Today. 2021;36:101051. doi: 10.1016/j.nantod.2020.101051. - DOI - PMC - PubMed
    1. Pardi N., Hogan M.J., Weissman D. Recent advances in mRNA vaccine technology. Curr. Opin. Immunol. 2020;65:14–20. doi: 10.1016/j.coi.2020.01.008. - DOI - PubMed
    1. Mulligan M.J., Lyke K.E., Kitchin N., Absalon J., Gurtman A., Lockhart S., Neuzil K., Raabe V., Bailey R., Swanson K.A., et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586:589–593. doi: 10.1038/s41586-020-2639-4. - DOI - PubMed
    1. Sahin U., Muik A., Derhovanessian E., Vogler I., Kranz L.M., Vormehr M., Baum A., Pascal K., Quandt J., Maurus D., et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T-cell responses. Nature. 2020;586:594–599. doi: 10.1038/s41586-020-2814-7. - DOI - PubMed

LinkOut - more resources